Abstract：Objective: To detect the expression of LncRNA MEG3 in peripheral blood mononuclear cells and sputum of children with viral bronchiolitis and analyze its clinical significance. Methods: 103 children with viral bronchiolitis admitted to Jiuting hospital and Songjiang Central Hospital from February 2017 to January 2019 were selected, and 103 healthy infants and children in the same period of physical examination were selected as the control group. After collecting peripheral blood mononuclear cells and sputum, the expression of LncRNA MEG3 was detected by qRT-PCR, and its relationship with clinicopathological characteristics and prognosis was analyzed. Results: The expression of LncRNA MEG3 in peripheral blood mononuclear cells and sputum of children in control, mild, moderate and severe groups decreased significantly in turn, and the differences between any two groups were statistically significant (P<0.05). The expression level of vascular endothelial growth factor (VEGF) mRNA in peripheral blood mononuclear cells and sputum of children in control, mild, moderate and severe groups increased significantly in turn, and the differences between any two groups were statistically significant (all P<0.05). The expression level of LncRNA MEG3 in peripheral blood mononuclear cells and sputum was negatively correlated with the expression level of VEGF mRNA (all P<0.05). The expression of LncRNA MEG3 in peripheral blood mononuclear cells and sputum of children with allergic history and post-discharge asthma was significantly lower than that of children without allergic history and concurrent asthma (P<0.05). Allergic history, high expression of VEGF and low expression of LncRNA MEG3 were risk factors for adverse prognosis in children with viral bronchiolitis (all P<0.05). Conclusions: The expression of LncRNA MEG3 in peripheral blood mononuclear cells and sputum decreased significantly in control, mild, moderate and severe groups, which may be related to the occurrence and development of viral bronchiolitis and the prognosis of children.
朱连海, 何长生, 申建伟, 杨丹平, 胡诤贇. LncRNA MEG3在病毒性毛细支气管炎患儿外周血单个核细胞和痰液中表达及意义[J]. 河北医学, 2020, 26(6): 946-950.
ZHU Lianhai, HE Changsheng, et al. Expression of LncRNA MEG3 in Peripheral Blood Mononuclear Cells and Sputum of Children with Viral Bronchiolitis and Its Significance. HeBei Med, 2020, 26(6): 946-950.
[1] 高月茹,程航,张英,等.2998例毛细支气管炎患儿流行病学特征及流行趋势[J].中国妇幼保健,2018,33(10):2276~2279. [2] 张海邻,吕芳芳.病毒性细支气管炎与哮喘相关性研究进展[J].中国实用儿科杂志,2017,32(12):895~900. [3] Tao XW, Zeng LK, Wang HZ, et al. LncRNA MEG3 ameliorates respiratory syncytial virus infection by suppressing TLR4 signaling[J]. Mol Med Rep, 2018, 17(3): 4138~4144. [4] Panciatici M, Fabre C, Tardieu S, et al. Use of high-flow nasal cannula in infants with viral bronchiolitis outside pediatric intensive care units[J]. Eur Pediatr, 2019, 178(10): 1479~1484. [5] Chang AB, Oppenheimer JJ, Rubin BK, et al. Chronic cough related to acute viral bronchiolitis in children: CHEST expert panel report[J]. Chest, 2018, 154(2): 378~382. [6] Zhang XY, Tang XY, Ma LJ, et al. Schisandrin B down-regulated lncRNA BCYRN1 expression of airway smooth muscle cells by improving miR-150 expression to inhibit the proliferation and migration of ASMC in asthmatic rats[J]. Cell Prolif, 2017, 50(6): 382~386. [7] Li X, Zheng M, Pu J, et al. Identification of abnormally expressed lncRNAs induced by PM2.5 in human bronchial epithelial cells[J]. Biosci Rep, 2018, 38(5): 1577~1582. [8] Li P, Gao Y, Li J, et al. LncRNA MEG3 repressed malignant melanoma progression via inactivating Wnt signaling pathway[J].Cell Biochem, 2018, 119(9): 7498~7505. [9] Zhang D, Qin H, Leng Y, et al. LncRNA MEG3 overexpression inhibits the development of diabetic retinopathy by regulating TGF-β1 and VEGF[J]. Exp Ther Med, 2018, 16(3): 2337~2342. [10] 刘振峰,梁治权,邓迎杰,等.骨性关节炎中lncRNAMEG3的表达及其与VEGF的相关性分析[J].中国医药导报,2018,15(16):8~12. [11] 王飞,季涛云,王亚军,等.咳嗽变异性哮喘患儿血清总IgE、VEGF、IL-4、IL-5、IL-13及外周血EOS表达水平与临床意义[J].临床肺科杂志,2019,24(2):266~270.
2020, Vol. 26 
冀公网安备13080202000677号